169 related articles for article (PubMed ID: 2479261)
1. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
Kishimoto W; Nakao A; Takagi H; Hayakawa T
Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261
[TBL] [Abstract][Full Text] [Related]
2. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
Takekoshi H; Oyama R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
[TBL] [Abstract][Full Text] [Related]
3. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].
Shi Z; Guo Y; Liu D
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839
[TBL] [Abstract][Full Text] [Related]
5. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Motohara T; Ozawa Z; Morita S
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
[TBL] [Abstract][Full Text] [Related]
6. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
Ohmoto K; Yamamoto R; Yamamoto S; Ideguchi S; Saito I; Wada A; Takatori K; Ohumi T; Hino K; Hirano Y
Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
[TBL] [Abstract][Full Text] [Related]
8. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma].
Ihaya T; Ametani M; Matsusue E
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698
[TBL] [Abstract][Full Text] [Related]
9. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma.
Khan KN; Nakata K; Kusumoto Y; Shima M; Ishii N; Koji T; Nagataki S
Cancer Res; 1991 Oct; 51(20):5667-71. PubMed ID: 1717151
[TBL] [Abstract][Full Text] [Related]
12. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
13. [Combined hepatic arterial infusion chemotherapy with transcatheter arterial embolization and hyperthermia in primary liver cancer].
Izumi R; Urade M; Kimura H; Kobayashi M; Yabushita K; Watanabe T; Fujimura T; Ohhori I; Itoh M; Yonemura Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2465-9. PubMed ID: 2843110
[TBL] [Abstract][Full Text] [Related]
14. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
15. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma].
Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119
[TBL] [Abstract][Full Text] [Related]
16. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of caerulein in suppressing post-TAE complications of the gallbladder].
Akamatsu K; Miyauchi S; Yasuhara Y; Mogami H; Nishimura N; Ohshima K; Ohta Y
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1094-9. PubMed ID: 3032112
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of preoperative transcatheter arterial embolization for improved survival rates in patients with hepatocellular carcinomas (sandwich therapy using ethiodized oil, cisplatin and gelatin sponge].
Shibata T; Sasaki Y; Imaoka S; Yasuda T; Wada H; Ishikawa O; Ohigashi H; Fukuda I; Kabuto T; Hiratsuka M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2514-9. PubMed ID: 2843115
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M
Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
[TBL] [Abstract][Full Text] [Related]
20. Rupture of hepatocellular carcinoma following transcatheter arterial embolization.
Nakao N; Kotake M; Miura K; Ohnishi M; Miura T
Radiat Med; 1988; 6(4):147-9. PubMed ID: 2850593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
